ArticleHepatology communications2023

Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.

Michihiro Iwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.